Your browser doesn't support javascript.
loading
Late relapse after hematopoietic stem cell transplantation for acute leukemia: a retrospective study by SFGM-TC.
Kaphan, Eléonore; Bettega, François; Forcade, Edouard; Labussière-Wallet, Hélène; Fegueux, Nathalie; Robin, Marie; Peffault De Latour, Régis; Huynh, Anne; Lapierre, Léopoldine; Berceanu, Ana; Marcais, Ambroise; Debureaux, Pierre-Edouard; Vanlangendonck, Nicolas; Bulabois, Claude-Eric; Magro, Leonardo; Daniel, Adrien; Galtier, Jean; Lioure, Bruno; Chevallier, Patrice; Antier, Chloé; Loschi, Michael; Guillerm, Gaelle; Mear, Jean-Baptiste; Chantepie, Sylvain; Cornillon, Jérome; Rey, Gaelle; Poire, Xavier; Bazarbachi, Ali; Rubio, Marie-Thérèse; Contentin, Nathalie; Orvain, Corentin; Dulery, Rémy; Bay, Jacques Olivier; Croizier, Carolyne; Beguin, Yves; Charbonnier, Aude; Skrzypczak, Caroline; Desmier, Déborah; Villate, Alban; Carré, Martin; Thiebaut-Bertrand, Anne.
Affiliation
  • Kaphan E; Department of Hematology-Transplantation, CHU Grenoble, Grenoble, France. Electronic address: eleonore.kaphan@aphp.fr.
  • Bettega F; Department of Clinical Research, Inserm, University Grenoble Alpes, CHU Grenoble Alpes, Grenoble, France.
  • Forcade E; Department of Hematology-Transplantation, Hôpital de Bordeaux, Bordeaux, France.
  • Labussière-Wallet H; Department of Hematology-Transplantation, CHU Lyon Sud, Pierre-Bénite, France.
  • Fegueux N; Department of Hematology, CHU Montpellier, Montpellier, France.
  • Robin M; Department of Hematology-Transplantation, Hôpital Saint-Louis, APHP, Université de Paris, Paris, France.
  • Peffault De Latour R; Department of Hematology-Transplantation, Hôpital Saint-Louis, APHP, Université de Paris, Paris, France.
  • Huynh A; Department of Hematology, Transplantation, and Cellular Therapy, IUCT Oncopole, Toulouse, France.
  • Lapierre L; Department of Hematology, Transplantation, and Cellular Therapy, IUCT Oncopole, Toulouse, France.
  • Berceanu A; Department of Intensive Care and Transplantation, CHU Jean Minjoz, Besançon, France.
  • Marcais A; Department of Hematology, Hôpital Necker, Paris, France.
  • Debureaux PE; Department of Hematology-Transplantation, Hôpital Saint-Louis, APHP, Université de Paris, Paris, France.
  • Vanlangendonck N; Department of Hematology, Université Catholique de Louvain, Louvain-la-Neuve, Belgium.
  • Bulabois CE; Department of Hematology-Transplantation, CHU Grenoble, Grenoble, France.
  • Magro L; Department of Hematology-Transplantation, CHRU Lille, Lille, France.
  • Daniel A; Department of Hematology, Université Catholique de Louvain, Louvain-la-Neuve, Belgium.
  • Galtier J; Department of Hematology-Transplantation, Hôpital de Bordeaux, Bordeaux, France.
  • Lioure B; Department of Hematology, CHRU Strasbourg, Strasbourg, France.
  • Chevallier P; Department of Hematology, CHU Nantes, Nantes, France.
  • Antier C; Department of Hematology, CHU Nantes, Nantes, France.
  • Loschi M; Department of Hematology-Transplantation, CHU Nice, Nice, France.
  • Guillerm G; Department of Hematology, CHRU Brest, Brest, France.
  • Mear JB; Department of Hematology-Transplantation, Hôpital de Rennes, Rennes, France.
  • Chantepie S; Basse-Normandie Hematology Institute, CHU Caen, Caen, France.
  • Cornillon J; Department of Clincial Hematology and Cellular Therapy, CHU Saint-Étienne, Saint-Priest-en-Jarez, France.
  • Rey G; Department of Clincial Hematology and Cellular Therapy, CHU Saint-Étienne, Saint-Priest-en-Jarez, France.
  • Poire X; Department of Hematology, CHU Saint-Luc, Brussels, Belgium.
  • Bazarbachi A; Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
  • Rubio MT; Department of Hematology, CHU Nancy, Nancy, France.
  • Contentin N; Department of Hematology, Centre Henri Becquerel, Rouen, France.
  • Orvain C; Department of Hematology-Transplantation, CHU Angers, Angers, France.
  • Dulery R; Department of Clinical Hematology, CHU St Antoine, APHP, Paris, France.
  • Bay JO; Department of Clinical Hematology and Cellular Therapy, CHU Estaing, Clermont-Ferrand, France.
  • Croizier C; Department of Clinical Hematology and Cellular Therapy, CHU Estaing, Clermont-Ferrand, France.
  • Beguin Y; Department of Hematology, University of Liège, Liège, Belgium.
  • Charbonnier A; Department of Hematology-Transplantation, CHU Amiens, Amiens, France.
  • Skrzypczak C; Department of Hematology-Transplantation, CHU Amiens, Amiens, France.
  • Desmier D; Department of Hematology, CHU Poitiers, Poitiers, France.
  • Villate A; Department of Hematology, CHRU Tours, Tours, France.
  • Carré M; Department of Hematology-Transplantation, CHU Grenoble, Grenoble, France.
  • Thiebaut-Bertrand A; Department of Hematology-Transplantation, CHU Grenoble, Grenoble, France.
Transplant Cell Ther ; 29(6): 362.e1-362.e12, 2023 06.
Article in En | MEDLINE | ID: mdl-36849078

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Transplant Cell Ther Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Transplant Cell Ther Year: 2023 Type: Article